Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minetta C Liu

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Journal of Biomedical Optics|November 13, 2007
Real-time imaging and characterization of human breast tissue by reflectance confocal microscopyMaddalena T Tilli, M Carla Cabrera, Angela R Parrish, et al.
Breast Cancer Research and Treatment|October 27, 2010
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancerClaudine Isaacs, Pia Herbolsheimer, Minetta C Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancerMinetta C Liu, Peter G Shields, Robert D Warren, et al.
JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.
Clinical Chemistry|September 22, 2018
Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy TestingDragana Milosevic, John R Mills, Michael B Campion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2018
Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic AdenocarcinomasMichael J Levy, Benjamin R Kipp, Dragana Milosevic, et al.
Breast Cancer Research and Treatment|April 17, 2013
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationshipVanessa B Sheppard, Claudine Isaacs, George Luta, et al.
Cancers|December 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced MelanomaClara Martínez-Vila, Cristina Teixido, Roberto Martín, et al.
Breast Cancer Research and Treatment|August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution studyGrace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 27, 2021
<i>BRAF</i> V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)Jessica A Slostad, Minetta C Liu, Jacob B Allred, et al.
Journal of Biomedical Optics|November 13, 2007
Real-time imaging and characterization of human breast tissue by reflectance confocal microscopyMaddalena T Tilli, M Carla Cabrera, Angela R Parrish, et al.
Breast Cancer Research and Treatment|October 27, 2010
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancerClaudine Isaacs, Pia Herbolsheimer, Minetta C Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2009
Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancerMinetta C Liu, Peter G Shields, Robert D Warren, et al.
JCO Precision Oncology|December 6, 2024
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete ResponseEric Michael Lander, Vasily N Aushev, Brandon M Huffman, et al.
Clinical Chemistry|September 22, 2018
Applying Standard Clinical Chemistry Assay Validation to Droplet Digital PCR Quantitative Liquid Biopsy TestingDragana Milosevic, John R Mills, Michael B Campion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 13, 2018
Analysis of Cell-Free DNA to Assess Risk of Tumoremia Following Endoscopic Ultrasound Fine-Needle Aspiration of Pancreatic AdenocarcinomasMichael J Levy, Benjamin R Kipp, Dragana Milosevic, et al.
Breast Cancer Research and Treatment|April 17, 2013
Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationshipVanessa B Sheppard, Claudine Isaacs, George Luta, et al.
Cancers|December 11, 2025
Personalized Circulating Tumor DNA Assay to Assess Long-Term Clinical Benefit in Patients with Advanced MelanomaClara Martínez-Vila, Cristina Teixido, Roberto Martín, et al.
Breast Cancer Research and Treatment|August 31, 2022
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution studyGrace M Choong, Savannah Liddell, Roberto A Leon Ferre, et al.
Pageof 16